2015

AMRI acquires Whitehouse Laboratories

Thursday, December 17, 2015

Global CRO Albany Molecular Research Inc. (AMRI) has acquired all the outstanding equity interests of Whitehouse Laboratories, a provider of testing services that includes chemical and material analysis, method development and validation, and quality-control verification services to the pharmaceutical, medical device and personal care industries. Total consideration is $54 million in cash, and an additional $2 million in shares of AMRI common stock contingent upon Whitehouse Labs achieving certain 2015 targets.

[Read More]

Oncology Alliance, GNS launch initiative for colorectal cancer

Wednesday, December 16, 2015

The Alliance for Clinical Trials in Oncology, one of the five cooperative research groups in the U.S. sponsored by the National Cancer Institute conducting large multicenter trials in oncology, and GNS Healthcare (GNS), a precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, have announced a big data initiative.

[Read More]

Merck wins innovation award from R&D Magazine

Wednesday, December 16, 2015

Merck, a Germany-based science and technology company, has received two R&D Magazine 100 awards—one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.

[Read More]